#COVID-19

FDA OK’s emergency use of Paxlovid

The Food and Drug Administration (FDA) last Friday (March 11) granted the emergency use authorization (EUA) for Pfizer’s anti-viral COVID-19 pill Paxlovid.

Official not keen or Level Zero sans hitting target jab rate

A health official said it is not yet time for the country to transition to Alert Level Zero or the new normal without meeting the country’s target COVID-19 vaccination rate.

BPO workers need adjustment time before resuming on-site work

MANILA – Partido Reporma senatorial candidate Guillermo Lorenzo Eleazar said workers who have been under the work from home arrangement since the start of the pandemic, particularly from the business process outsourcing (BPO) sector, should be given enough period of adjustment before they are required to go back to their offices.

DOH intensifies strategy against Deltacron variant

MANILA – The Department of Health (DOH) continues to strengthen its prevent-detect-isolate-treat-reintegrate (PDITR) strategies amid the warning on the possible spread of the recombinant virus of the Delta-Omicron (Deltacron) variants.

CDC: Pfizer-BioNTech COVID-19 vaccine greatly reduces risk of Omicron infection among children

Two doses of Pfizer-BioNTech COVID-19 vaccine greatly reduced the risk of Omicron infection among children aged 5 to 15, according to a study published by the U.S. Centers for Disease Control and Prevention (CDC) on Friday, March 11.

IATF to base new alert levels on ‘latest’ COVID-19 data, metrics

The Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF) will base its decision on the new alert level classifications in the country after March 15 on the “latest” coronavirus disease 2019 (COVID-19) and alert level matrix.

Popular